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ABSTRACT. Mosquitoes collected during the epidemic of West Nile virus (WN) in Staten Island, NX during
2000 were identified to species, grouped into pools of up to 50 individuals, and tested for the presence of WN
by using TaqMan@ reverse transcriptase polymerase chain reaction (RT-PCR) to detect West Nile viral RNA,
Vero cell plaque assay to detect infectious vir-us, and VecTest@ WNV/SLE Antigen Panel Assay. A total of
10,866 specimens was tested in 801 pools. Analysis of results indicated that TaqMan RT-PCR detected 34 WN-
positive pools, more than either of the other techniques. The plaque assay detected 74Vo of the pools positive
by TaqMan, and VecTest detected 6OVo of the pools positive by TaqMan. The VecTest assay detected evidence
of West Nile viral antigen in 67Vo of the pools that contained live virus detected by plaque assay. A WN enzyme
immunoassay perfbrmed similarly to the VecTest WN assay. Differences in performance were related to relative
sensitivity of the tests. Infection rates of WN in Culex pipiens and Cx. salinarius calculated by the 3 techniques
varied, but each estimate indicated a high infection rate in the population. Positive and negative attributes of
each procedure, which may influence how and where they are used in surveillance programs, are discussed.
KEY WORDS West Nile virus, surveillance, ThqMan@, reverse transcriptase polymerase chain reaction, plaque
assay, VecTest@, enzyme immunoassay, mosquito, vector
INTRODUCTION
During the 2 years after the introduction of West
Nile virus (WN) into the USA in 1999 (Centers for
Disease Control [CDC] 1999), the virus spread to
27 states and the District of Columbia in the eastern
half of the country (CDC 2001). In anticipation of
this expanding distribution, many state and local
health agencies and mosquito control districts ini-
tiated new arbovirus surveillance programs or ex-
panded existing programs. Four basic types of sur-
veillance were recommended as important in
monitoring WN activity (avian, mosquito, veteri-
nary, and human), with mosquito-based surveil-
lance (i.e., monitoring mosquito population density
and virus infection rate) identified as a mainstay of
the programs (Gubler et al. 2000).
The expanded surveillance programs and the
markedly increased number of mosquitoes to be
processed prompted development of efficient, rapid
procedures for analyzing the specimens. As a re-
sult, automated RNA extraction and reverse tran-
scriptase polymerase chain reaction (RT-PCR) pro-
cedures for detecting West Nile viral RNA
(Lanciotti et al. 2000, Hadfield et al. 2001, Shi et
al. 2001) replaced standard cell culture assays for
live virus (Beaty et al. 1989) as the preferred tools
for screening large numbers of mosquito pools in
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surveillance programs beginning in 2000. Subse-
quently, a commercially available dipstick test for
detecting WN antigen in mosquito pools was de-
veloped (VecTest@ WNV/SLE Antigen Panel As-
say, Medical Analysis Systems, Inc., Camarillo,
CA) and was utilized in a few surveillance pro-
grams during 20O1. Late in the course of this study,
an antigen-capture enzyme immunoassay (AC-EIA)
for WN was developed (Hunt et al.2OO2).
Our preliminary evaluation of the VecTest kits
indicated that they could detect and differentiate
WN and St. Louis encephalitis virus (SLE) in seed
virus stocks, in virus-positive mosquitoes produced
by laboratory inoculation, and in field-collected
WN-positive mosquito pools (Ryan et al., in press).
The sensitivity and speciflcity characteristics of the
WN AC-EIA (Hunt et al. 2OO2) seem to be similar
to those of the VecTest WN assay.
Discrepancies in the number of WN-positive
mosquito pools in field collections detected by RT-
PCR, cell culture assay (Bernard et al. 2001, Nasci
et al. 2001, White et al. 2001), and VecTest dip-
sticks (unpublished data) have occurred and are at-
tributed to differences in the sensitivities of the pro-
cedures. The purpose of this research was to
compare the ability of RT-PCR, cell culture, and
WN VecTest assays to detect WN in a large number
of field-collected mosquitoes and to evaluate their
respective uses in mosquito-based WN surveillance
programs. In addition, we were able to do a prelim-
inary evaluation of the WN AC-EIA with field-col-
lected WN-positive mosquito pools.
MATERIALS AND METHODS
Mosquitoes used in this study were collected
with COr-baited CDC miniature light traps and
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CDC gravid traps from June 2 through December
12,2OOO, in Staten Island (Richmond County), NY,
as part of the New York City Department of Health
WN surveillance program (Kulasekera et al. 2001).
These were extra specimens not tested during the
regular surveillance season. Tiaps were set in the
late afternoon or evening and retrieved the follow-
ing morning. Specimens were immediately frozen
and held at -7O"C. Before testing for virus, mos-
quitoes were identified to species at the New York
City Department of Health by using morphological
characteristics, and sorted into pools of up to 50
individuals, based on species, date, and site of col-
lection. Identification and sorting were done on a
chill table to help retain virus viability. Pooled mos-
quitoes were refrozen at -70'C and shipped on dry
ice to the CDC Division of Vector-Borne Infectious
Diseases for testing.
Pooled mosquitoes were placed in 2.0-ml snap-
cap microcentrifuge tubes (HS4264J, Daigger and
Co., Lincolnshire, IL) with 1 copper-coated, 4.5-
mm-diameter steel bead (Airgun Shot, Steel BB
Cal, premium grade BBs, Copperhead, East Bloom-
field. NY) and I.7 ml of BA-l diluent (lX M199
with Hanks' balanced salt solution, 0.05 M Tfis
buffer [pH 7.6], lVo bovine serum albumin, 0.35 g/
liter sodium bicarbonate, 100 mg/liter streptomycin,
and 1 mg/ml Fungizone [Sigma-Aldrich, St. Louis,
MOI). The mosquitoes were then homogenized by
placing the tubes in a Qiagen Mixer Mill MM 300
(QIAGEN Inc., Valencia, CA), which is designed
to disrupt biological samples through the beating
and grinding effect of the steel bead on the sample
material as they are shaken together in the tube.
The mixer mill can homogenize 48 pools at a time,
and was operated in a high-efficiency particulate
air-filtered, laminar flow biosafety cabinet at 25 cy-
cles/sec for 4 min. After homogenization, the spec-
imens were centrifuged at 4,000 rpm for 3 min with
an aerosol-block rotor in a refrigerated microcen-
trifuge.
Each mosquito pool was tested for the presence
of West Nile viral RNA by using a ThqMano RT-
PCR assay described by Lanciotti et al. (2000).
Briefly, RNA was extracted from 140 pl of the
mosquito homogenate by using QIAamp viral RNA
kits (QIAGEN). The RNA was eluted from the
QIAgen columns in a final volume of IOO pl of
elution buffer and stored at -7O"C until used. For
the TaqMan test, 5 pl of RNA was combined with
the appropriate primers and probes by using the
TaqMan RT-PCR Ready-Mix Kit (PE Applied Bio-
systems, Foster City, CA). The samples were sub-
jected to 45 cycles of amplification in an ABI Prism
7700 Sequence Detection System instrument (PE
Applied Biosystems) according to the manufactur-
er's protocol for TaqMan RT-PCR cycling condi-
tions. All pools were screened with the ENV prim-
ers/probe (genome positions: forward 1, I 60-1, I 80;
reverse 1,2O9-1,229; probe 1,186-1,207) and those
producing positive results were confirmed as posi-
tive with the 3'NC primers/probe (genome posi-
tions: forward 10,668-10,684; reverse I0,110-
1O,756; probe L0,691-10,714). Pools were
considered positive only if they gave positive re-
actions with both probes.
Vero cell plaque assay in 6-well plates (Beaty et
al. 1989) with a double agar overlay was used to
detect live virus in the pools. Supernatant from the
homogenized mosquito pool (100 pl) was inocu-
lated into each of 2 wells on a 6-well plate con-
taining a confluent Vero cell monolayer and held
for t h at 37"C; the cells then were overlayed with
3 ml of agar (l7o Noble agar in M199, 0.35 g/liter
sodium bicarbonate, 100 mglliter streptomycin, I
mg/ml Fungizone, and 150 g/ml diethylaminoethyl-
dextran) and incubated at 37"C. On the 4th day af-
ter inoculation, a 2nd agar overlay was placed on
each well (3 ml/well identical to the lst overlay
except for the addition of 4 mVliter l%o nettral red
to the agar). The plates then were observed daily
for 10 days for evidence of plaques. The number
of plaques observed in each positive well was re-
corded and cell sheets in wells showing plaques
were harvested and tested for virus identification
by using the WN-specific, TaqMan real-time RT-
PCR described above.
The VecTest WNV/SLE Antigen Panel Assay
was used to detect West Nile viral antigen in the
mosquito pools. This is a qualitative, immunoch-
romatographic test that uses type-specific monoclo-
nal antibodies to detect WN or SLE antigen in mos-
quito pools. According to the package instructions,
mosquito pools containing up to 50 individuals are
ground in 2.5 ml of the grinding solution provided
with the kit. After grinding, the homogenate may
be centrifuged to remove debris (an optional step,
not required for the test to run), and 250 pl of the
homogenate is dispensed into a 1.7-ml conical-bot-
tom tube provided in the kit. A test strip is inserted
into the tube for 15 min. After 15 min, the strip is
removed from the tube and examined. As the mos-
quito homogenate migrates up the strip, viral anti-
gen, if present, reacts with type-specific, colloidal
gold-conjugated monoclonal antibodies contained
in the bottom portion of the strip. The antigen-an-
tibody-gold complexes then migrate through the
test zone containing immobilized antibody where
they are bound and accumulate to form a visible,
reddish purple line (Fernandez et al. 1994). The test
zone has 2 virus-specific areas, I for WN and I for
SLE (Fig. l). Unbound dye complexes migrate out
of the test zone and are captured in the control
zone, which shows a line indicating that the ho-
mogenate has migrated through the test zone. Un-
less the control line is present, the test is invalid.
Preliminary tests with laboratory-infected, WN and
SlE-positive and -negative mosquito pools dem-
onstrated the ability of the VecTest assay to detect
and differentiate the virus antigens in mosquito
pools (Ryan et al., in press).
We departed from the VecTest recommended
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Fig. 1. A VecTest@ WNV/SLE Antigen Panel Assay
Test strip indicating relative position of West Nile virus
positive indicator line, St. Louis encephalitis virus positive
indicator line, and control zone line, demonstrating that
the sample migrated through the test zone.
grinding procedure because we wanted to be able
to test the pools for live WN with the plaque assay,
and preliminary tests indicated that the grinding so-
lution provided with the VecTest kit rendered WN
in the mosquito pools noninfectious in cell culture
(we were unable to recover infectious virus from
WN and SLE seed stocks mixed 1:10 with the
VecTest grinding buffer then serially diluted with
BA-l medium, but were able to recover infectious
eastern equine encephalomyelitis and western
equine encephalomyelitis viruses treated similarly
[unpublished data]). We used the mosquito homog-
enate ground in BA-1 medium described above,
mixed 1 : I with the VecTest grinding medium (125
pl of mosquito homogenate and 125 pl of VecTest
grinding medium) in the conical-bottom tube before
inserting the VecTest strip. As a result, the material
tested with VecTest strips was diluted 1 : I in com-
parison to the concentration of homogenate tested
with TaqMan and cell culture assays (i.e., virus
concentration in the positive pools was reduced by
0.3 log'0 plaque-forming units [PFU]/ml), and com-
ponents of the VecTest grinding medium designed
to optimize test performance (e.g., detergents) also
were  d i lu ted  1 :1 .
All of the pools were tested with TaqMan RT-
PCR and the positives from that test were subse-
quently tested with the plaque and VecTest assays.
In addition, 135 TaqMan-negative pools were tested
with the plaque and VecTest assays to examine the
potential for the VecTest assay to produce false-
positive results. All tests were done blind, without
the investigator having prior knowledge of the re-
sults from the other tests.
Mosquito pools positive by RT-PCR with suffl-
cient material remaining after other testing was
completed also were tested with a WN AC-EIA
(Hunt et al. 2OO2). This test is essentially identical
to the AC-EIA test for SLE (Tsai et al. 1987), but
replaces the SlE-specific capture and detection an-
tibodies with WN-specific antibodies. The AC-EIA
protocol consists of an antigen-capture assay fol-
lowed by a confirmatory inhibition assay. Speci-
mens were called positive only if confirmed in the
inhibition assay.
The impact of variation in number of positives
detected by the different tests on the data used by
mosquito-based surveillance systems was evaluated
by estimating the WN infection rate (IR) with the
results from each ofthe assays for the Culex pipiens
L. and Culex salinarius Coquillett collected during
August, and correcting for variable pool sizes (Wal-
ter et al. 1980). Meaningful IRs could not be cal-
culated for other species or other months because
fewer than 1,000 specimens were available for test-
ing for the month or no positives were found during
the month with any of the assays. The estimated IR
was expressed as the number of positive pools col-
lected per 1,000 specimens tested (Nasci and
Mitchell 1996).
RESULTS
A total of 10,866 mosquitoes in 801 pools, rep-
resenting 23 mosquito species, was provided by the
New York City Department of Health (Table l).
The TaqMan assay detected WN RNA in 34 pools,
most of which contained, Cx. pipiens or Cx. sali-
narius. Of the 34 TaqMan-positive pools, 25 (747o)
pools were positive in cell culture and 18 (6OVo) of
30 were WN-positive in the VecTest WNV/SLE
Antigen Panel Assay (4 of the TaqMan-positive
pools tested with plaque assay were not tested with
VecTest because of insufficient volume remaining
after other manipulations).
Table 2 shows the results from each of the 3
tests. When using TaqMan results as the basis for
comparison, no false positives were found in the
plaque assay or VecTest. Pools positive with plaque
assay, VecTest, or both also were ThqMan-positive.
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Table 1. Mosquitoes tested for evidence of West Nile virus (WN) by using TaqMan@ reverse transcriptase
polymerase chain reaction and results of testing the TaqMan WN-positive pools with Vero cell culture plaque assay
and VecTest@ WNV/SLE Antigen Panel Assav.
No. positive pools'
Species TaqMan
Plaque
assay
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No.
pools
No.
specimens VecTest
Aedes albopictas (Skuse)
Ae. vexans (Meigen)
Anop he le s ba rb e ri Coquillett
An. crucians Wiedemann
An. punctipennis (Say)
An. quadrimaculatus Say
An. sp.
Coquillettidia perturbans (Walker)
Culex erraticus (Dyar and Knab)
Cx. pipiens/restaans mixed pools
Cx. pipiens L.
Cx. restuans Theobald
Cx. salinarius Coquillett
C.r. sp.
Cx. territetns Walker
Ochle rotatus atropalpus (Coquillett)
Oc. canadensis (Theobald)
Oc. cantator (Coquillett)
Oc. dorsalis (Meigen)
Oc. grosbecki (Dyar and Knab)
0c. sollicitans (Walker)
Oc. sp.
Oc. taeniorhyncftzs (Wiedmann)
Oc. triseriatus (Say)
Oc. trivittatus (Coquillett)
Psorophora ferox (Von Humboldt)
Uranotaenia. sapphirina (Osten Sacken)
Total
J
96
I
A
26
72
7
35
2
20
133
3 Z
2 1 2
2 l
1 l
1
3
27
z
2
1 6
37
I
55
29
8
5
801
3
834
1
4
49
28
1 8
103
8
229
1,928
210
6,144
284
t 4
1
3
192
1 2
5
284
241
I
777
69
t7
9
r0,866
12
2
15,
143
z
2
1 3 9
8
1
8
2
25
'Only the TaqMm-positive pools and 135 negative pools were tested with plaque assay and VecTest assay.
'One of the TaqMan-positive pools for this species was not tested with the VecTest strips because of insufficient volume.
3 Two of the TaqMan-positive pools for this species were not tested with the VecTest strips because of insufficient volume
The 3 assays agreed in 16 (53Vo) of 30 TaqMan-
positive pools. In 8 (27Va) of 30 pools, the plaque
assay and ThqMan were positive but the VecTest
was negative, and in 2 (6Eo) of 3O pools, the
VecTest and TaqMan were positive but the plaque
assay was negative. The VecTest detected 16 (67Vo)
of 24 of the pools that were positive in plaque as-
say, and also detected WN antigen in 2 pools that
were TaqMan-positive but plaque assay-negative.
No evidence of WN was found in the 135 pools
that were negative by TaqMan when tested with
plaque assay or VecTest. None of the pools pro-
duced an SlE-positive reaction in the VecTest as-
say.
Table 2. Results from TaqMano reverse transcriptase polymerase chain reaction (RT-PCR); Vero cell culture plaque
assay, and VecTest@ WNV/SLE Antigen Panel Assay on 8O1 field-collected mosquito pools.
WN assay results
ThqMan RT-PCR
(34 positives)
Plaque assay
(25 positives)
VecTest
(18 positives) No. pools
t 6
8
I
2
J
4
135
632
801
+
+
+
+
+
+
+
+
+
+
Not tested
+
Not tested
Not tested
Total
Not tested
298 JounNel op rHs AvEntcAN MoSQUITo Courrol AssoctattoN Vor-. 18, No. 4
34
E : o
3 z r
G 2 6
9 z t
2 z o
E t r
F v
2 3 2
e 1 0
Q 2 E
e 2 6
> 2 46 r )
? 2 0
l8
- o h - - = 9 9 ! 3 F R K F R H 3
Pool Number*
Fig. 2. The TaqMan-positive pools ranked by cycle
threshold (Ct) number from lowest to highest (highest to
lowest West Nile virus titer), indicating positive (black
bars), negative (hatched bars), and not tested (white bars)
pools lbr pools tested with Vero cell plaque assay (top
panel) and VecTest assay (bottom panel).
Sufficient sample material to allow testing with
the WN AC-EIA remained from only l5 of the RT-
PCR-positive pools. Of these, plaque assay detect-
ed 13 (87Vo), AC-EIA detected 13 (87Vo), and
VecTest detected 1l (73Vo) pools. No difference
was found in the proportion of positive pools de-
tected by AC-EIA and VecTest assays (12 : 0.003,
P > 0.05).
The association between TaqMan cycle threshold
(Ct) number in the 34 RNA-positive pools (when
using the 3'NC probe) and detection by cell culture
or VecTest is shown in Fig. 2. The TaqMan Ct is
the cycle number at which fluorescence increases
above the background threshold. The Ct value is
directly related to the amount of RNA in the sample
and is correlated with the titer of viable virus in the
sample (Lanciotti et al. 2000). Lower Ct values in-
dicate higher concentrations of viral RNA, and
higher virus titers in the sample. The VecTest assay
detected West Nile viral antigen in l7 of 17
TaqMan positives with Ct < 28, but only detected
| (8Vo) of 13 with Ct> 28. Vero cell culture plaque
assay detected live virus in l6 (897o) of l8
TaqMan-positive pools with Ct < 28, and 9 (56Va)
of 16 pools with Ct > 28. In this assay, a TaqMan
Ct of 28 correlated with approximately 3.5-4.0
logr0 PFU/ml in the Vero cell plaque assay (Lan-
ciotti et al. 2000).
The WN infection rate (IR) estimated for mos-
quitoes collected during August ranged from 5.2
(VecTest) to 8.8 (TaqMan) for Cx. pipiens and from
7.1 (VecTest) to I2.l (TaqMan) for Cx. salinarius
(Table 3).
DISCUSSION
Mosquito-based arbovirus surveillance programs
traditionally have used detection of infectious virus
in cell culture or vertebrate test systems for deter-
mining the presence and relative abundance of vi-
rus in a mosquito population. ln our evaluation of
WN in fleld-collected mosquitoes, Vero cell culture
plaque assay was not as sensitive as a procedure to
detect West Nile viral RNA in mosquito pools, but
was more sensitive than a procedure to detect West
Nile viral antigen in the pools. These results are
consistent with published accounts of the perfor-
mance of viral RNA (Lanciotti et al. 2000, Bernard
et al. 2001) or viral antigen detection systems (Hil-
dreth et al. 1984, Tsai et al.1987, Hunt et al.2OO2)
in the laboratory and field. In this project, the
TaqMan real-time RT-PCR procedure detected ev-
idence of West Nile viral RNA in 367o more pools
than plaque assay detected live virus, and the
VecTest WNV/SLE assay detected evidence of
West Nile viral antigen in only 67Vo of the pools
that contained live virus. Stated another way,
plaque assay identified 74Vo of the TaqMan-positive
pools and VecTest identified 6OVo of the TaqMan
positives.
The difference in ability to detect evidence of
WN in a mosquito pool is primarily related to the
sensitivity of the tests. The TaqMan Ct values of
the plaque assay and VecTest positive and negative
pools demonstrated that pools containing higher
amounts of viral RNA were more likely to be de-
tected with the other techniques. The VecTest
Table 3. Number of positive pools and estimated infection rate from pools of CuLex pipiens and Cx. salinarius
collected during August 2000 on Staten Island, NY, tested with 3 assays.
No. positive pools Infection ratet (957o confidence interval)
Species
No.
specimens TaqMan@
Plaque
Assay VecTes@
No.
pools
Cx. pipiens
Cx. salinarius
1 3
8.8
(5.0-14.6)
l l
12.1
(6.s-21.3)
il
7 .2
(4.o-12.6)
8
8.3
(4.0-16.0)
8
5 .2
(2.6-10.0)
7
7 . 1
(3.3-14.2)
| ,675
I , l  l 5 65
I IR, estimated infection rate, expressed as number of positive pools per 1,000 specimens tested
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WNV/SLE assay detected West Nile viral antigen
in all of the pools containing a minimum of 3.5-
4.0 logr0 PFU/ml of virus (estimated Vero cell
plaque assay equivalent). The plaque assay was ca-
pable of detecting infectious virus in pools with the
highest Ct values (i.e., lowest titer pools detected
by ThqMan), but was less likely to do so as Ct
values increased. This is related to the probability
of virus being present in the aliquot being tested.
Our standard plaque assay protocol tests approxi-
mately l07o of the total mosquito pool homogenate.
The plaque assay would probably detect virus in
greater proportion of the low-titer pools if a greater
proportion of the total pool material was tested.
Although less sensitive than the plaque assay, the
VecTest assay detected viral antigen in 2 pools that
did not produce live virus in plaque assay. This
indicates that the VecTest assay is similar to other
antigen detection systems in its ability to detect vi-
ral antigen from mosquito pools containing killed
virus (Tsai et al. 1987, Hunt et al. 2OO2), and that
specimens need not be maintained in a continuous
cold chain to detect the presence of viral antigen
with this test. Standard RT-PCR and ThqMan RT-
PCR assays share this characteristic, and do not re-
quire a cold chain to be effective (Kramer et al.
2001, Turell et al. 2OO2). Although this character-
istic may be used to reduce cost associated with
surveillance programs, it should be noted that lack
of a cold chain compromises the ability to isolate
infectious virus for further study and to detect any
virus that will grow in cell culture.
Although differences were demonstrable in sen-
sitivity and in the number of positive pools detected
by the 3 techniques, the effect on the estimated IRs
calculated during August 2000 for 2 species was
negligible. The highest IRs, calculated with the
TaqMan results, were 1.5- to l.7-fold greater than
the lowest IRs calculated with the VecTest results,
and considerable overlap occurred in tl:re 95Vo con-
fidence intervals around the IR estimates. There-
fore, analysis of the data indicated a high infection
rate in the mosquito populations regardless of the
test system used.
In summary, TaqMan RT-PCR, cell culture, and
VecTest WNV techniques detected evidence of WN
in field-collected mosquito pools, and despite dif-
ferences in sensitivity, each provided evidence of
high infection rates in key mosquito populations.
The WN AC-EIA performed similarly to the
VecTest WNV assay in the limited testing that was
possible. Although appearing to be relatively equal
in ability to provide an index of virus activity in a
mosquito population, TaqMan RT-PCR, cell cul-
ture, and VecTest WNV have positive and negative
attributes that should be considered when deciding
which to use in a surveillance program. The
TaqMan RT-PCR is extremely sensitive, provides
the highest probability that early-season transmis-
sion will be detected when IRs in the mosquito
populations are low, and does not require a cold
chain. However, TaqMan is very costly and requires
specialized equipment and trained personnel.
Plaque assay is also very sensitive, and it has the
added beneflt of being able to detect any virus that
will grow in Vero cells with a single test. This trait
that makes plaque assay very attractive to surveil-
lance programs that must detect several potential
arboviruses. However, viruses that are isolated with
plaque assay must be identified by using different
techniques, and plaque assay is costly, requiring
specialized equipment and trained personnel. The
VecTest assay is less sensitive than TaqMan RT-
PCR and plaque assay, but is relatively inexpen-
sive, doesn't require costly equipment or specially
trained personnel, and can test for WN and SLE on
the same strip. The VecTest SLE assay and the WN
AC-EIA share many of the positive aspects of the
VecTest WNV assay, but they have not been ade-
quately field tested yet. The comparatively lower
sensitivity of the VecTest means that a greater like-
lihood exists of not detecting early season trans-
mission when IRs are low. This may be overcome
by testing larger numbers of specimens early in the
season. Further investigations of how these assays
perforn, particularly in other geographic regions
and with other mosquito communities, are needed
to provide a basis for determining their use in sur-
veillance programs designed to monitor the events
and conditions that may lead to epizootics and ep-
idemics (Moore et al. 1993).
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